TechValidate Research on PulsePoint

PulsePoint Case Study

Global 500 Pharmaceuticals Company


This case study of a Global 500 pharmaceuticals company is based on a January 2021 survey of PulsePoint customers by TechValidate, a 3rd-party research service. The profiled company asked to have their name blinded to protect their confidentiality.


The business challenges that led the profiled company to evaluate and ultimately select PulsePoint:

  • They chose Pulsepoint to solve for the challenge(s) of:
    • Limited health targeting options
    • Regulatory concerns

Use Case

The key features and functionalities of PulsePoint that the surveyed company uses:

  • Said what % of their health budgets are/will be spent programmatically in the following time frames:
    • today are: 15-29%
    • in 2 years will be: 45-59%
    • in 5 years will be: +60%


The surveyed company achieved the following results with PulsePoint:

  • As a result of using PulsePoint’s Life platform, they have experienced or expect to experience the following:
    • Reduced costs
    • Improved control
    • Differentiation and innovation for clients
    • Increase of Return on Ad Spend (ROAS)
    • Unified campaign measurement

About This Data

This data was sourced directly from verified users of PulsePoint by TechValidate.

TechValidate verifies the identity and organizational affiliation of all participants that contribute to published research data. When research participants so desire, we also guarantee their anonymity so that they may share information honestly and freely.

More Research on PulsePoint